ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC31785-1mg |
|
1195941-38-8 |
SAR-100842
|
0 | C27H27NO5 | |
GC31785-10mM(1mLinDMSO) |
|
1195941-38-8 |
SAR-100842
|
0 | C27H27NO5 | |
GC31784-10g |
|
102-60-3 |
Quadrol (N,N,N′,N′-Tetrakis(2-hydroxypropyl)ethylenediamine)
|
0 | C14H32N2O4 | |
GC31784-10mM(1mLinDMSO) |
|
102-60-3 |
Quadrol (N,N,N′,N′-Tetrakis(2-hydroxypropyl)ethylenediamine)
|
0 | C14H32N2O4 | |
GC31783-50mg |
|
2150-43-8 |
Methyl 3,4-dihydroxybenzoate (Protocatechuic acid methyl ester)
|
0 | C8H8O4 | |
GC31783-10mM(1mLinDMSO) |
|
2150-43-8 |
Methyl 3,4-dihydroxybenzoate (Protocatechuic acid methyl ester)
|
0 | C8H8O4 | |
GC31782-100mg |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31782-50mg |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31782-25mg |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31782-10mg |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31782-5mg |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31782-2mg |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31782-10mM(1mLinDMSO) |
|
135-87-5 |
Piperoxan hydrochloride (Benodaine hydrochloride)
|
0 | C14H20ClNO2 | |
GC31781-100mg |
|
152-95-4 |
Sophoricoside
|
0 | C21H20O10 | |
GC31781-50mg |
|
152-95-4 |
Sophoricoside
|
0 | C21H20O10 | |
GC31781-10mg |
|
152-95-4 |
Sophoricoside
|
0 | C21H20O10 | |
GC31781-10mM(1mLinDMSO) |
|
152-95-4 |
Sophoricoside
|
0 | C21H20O10 | |
GC31780-50mg |
|
2097132-94-8 |
Pralsetinib (Blu667)
|
0 | C27H32FN9O2 | |
GC31780-2mg |
|
2097132-94-8 |
Pralsetinib (Blu667)
|
0 | C27H32FN9O2 | |
GC31780-100mg |
|
2097132-94-8 |
Pralsetinib (Blu667)
|
0 | C27H32FN9O2 | |